Replies to post #508210 on NorthWest Biotherapeutics Inc (NWBO)

[X Master]

The original trial design permitted the placebo patients to cross over after progression. After progression, the tumor was removed and the patient received the same treatment as the newly diagnosed. Both groups lived longer than the SOC achieving statistical significance. Your efforts to discredit NWBO are baseless.

[Roman516]

Again, if you take in consideration and discard personal opinions, the focus is on the fact that there are many doctors, scientist and professional that agree with the data results.

[CherryTree1]

With all due respect I think you need to read the press release.
How do they accomplish this without a final SAP?

The statisticians will proceed as quickly as possible with analyses of the raw data and prepare summaries of the Trial results for review by the Company, the Principal Investigator, the Steering Committee of the Trial, the Scientific Advisory Board, and a panel of independent brain cancer experts, who will analyze the data with the statisticians in preparation for public announcement and scientific publication.

They can't

[Dr Bala]

Absolute nonsense.

[dr_lowenstein]

absolutely correct, good stuff